Top story

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

Read full story

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

The New York Times - Drugs & Pharmaceuticals

By Gina Kolata, Rebecca Robbins and Carolyn Y. Johnson - Wed, 26 Aug 2026

Trump Will End Subsidies for Medicare Drug Premiums

The New York Times - Drugs & Pharmaceuticals

By Rebecca Robbins and Reed Abelson - Wed, 29 Jul 2026

Trump’s New Trade Fights (and Deals)

The New York Times - Drugs & Pharmaceuticals

By Andrew Ross Sorkin, Bernhard Warner, Sarah Kessler, Michael J. de la Merced, Niko Gallogly, Brian O’Keefe, Ian Mount and Lauren McCarthy - Wed, 22 Jul 2026

Trump Plans to Impose Tariffs on Generic Drugs

The New York Times - Drugs & Pharmaceuticals

By Rebecca Robbins - Wed, 22 Jul 2026

Shortage of Chemotherapy Drugs Brings Rationing Fears for Cancer Patients

The New York Times - Drugs & Pharmaceuticals

By Christina Jewett - Wed, 24 Jun 2026

RFK Jr. Defends Trump’s Mathematically Impossible Drug Discount Claims

The New York Times - Drugs & Pharmaceuticals

By Chris Cameron - Wed, 22 Apr 2026

Monthly News Roundup - December 2025

Drugs.com - News for Health Professionals

Wed, 31 Dec 2025

Why Your Gut May Stall Out And What To Do About It

Drugs.com - Daily MedNews

Wed, 31 Dec 2025

Veterans Affairs Chief on Harassment: 'Behavior is Either Acceptable or It is Not'

Drugs.com - Daily MedNews

Wed, 31 Dec 2025